Cargando…
Current pharmacological treatments for SARS-COV-2: A narrative review
The novel coronavirus, later identified as SARS-CoV-2, originating from Wuhan in China in November 2019, quickly spread around the world becoming a pandemic. Despite the knowledge of previous coronaviruses, such as those responsible for the SARS and MERS-CoV epidemic, there is no drug or prophylaxis...
Autores principales: | Nittari, Giulio, Pallotta, Graziano, Amenta, Francesco, Tayebati, Seyed Khosrow |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320862/ https://www.ncbi.nlm.nih.gov/pubmed/32603692 http://dx.doi.org/10.1016/j.ejphar.2020.173328 |
Ejemplares similares
-
Telemedicine in the COVID-19 Era: A Narrative Review Based on Current Evidence
por: Nittari, Giulio, et al.
Publicado: (2022) -
Telerehabilitation: Review of the State-of-the-Art and Areas of Application
por: Peretti, Alessandro, et al.
Publicado: (2017) -
Brain and Retinal Organoids for Disease Modeling: The Importance of In Vitro Blood–Brain and Retinal Barriers Studies
por: Martinelli, Ilenia, et al.
Publicado: (2022) -
Telemedicine framework to mitigate the impact of the COVID-19 pandemic
por: Battineni, Gopi, et al.
Publicado: (2021) -
Telemedicine Practice: Review of the Current Ethical and Legal Challenges
por: Nittari, Giulio, et al.
Publicado: (2020)